全文获取类型
收费全文 | 38510篇 |
免费 | 1744篇 |
国内免费 | 725篇 |
专业分类
耳鼻咽喉 | 652篇 |
儿科学 | 893篇 |
妇产科学 | 494篇 |
基础医学 | 1148篇 |
口腔科学 | 586篇 |
临床医学 | 3275篇 |
内科学 | 4943篇 |
皮肤病学 | 613篇 |
神经病学 | 2215篇 |
特种医学 | 896篇 |
外科学 | 5730篇 |
综合类 | 6700篇 |
一般理论 | 1篇 |
预防医学 | 2998篇 |
眼科学 | 562篇 |
药学 | 4376篇 |
50篇 | |
中国医学 | 2246篇 |
肿瘤学 | 2601篇 |
出版年
2024年 | 16篇 |
2023年 | 490篇 |
2022年 | 1119篇 |
2021年 | 1383篇 |
2020年 | 1386篇 |
2019年 | 1318篇 |
2018年 | 1406篇 |
2017年 | 1091篇 |
2016年 | 1301篇 |
2015年 | 1311篇 |
2014年 | 3252篇 |
2013年 | 3140篇 |
2012年 | 2769篇 |
2011年 | 3046篇 |
2010年 | 2622篇 |
2009年 | 2182篇 |
2008年 | 2004篇 |
2007年 | 1886篇 |
2006年 | 1580篇 |
2005年 | 1328篇 |
2004年 | 1126篇 |
2003年 | 1036篇 |
2002年 | 853篇 |
2001年 | 772篇 |
2000年 | 513篇 |
1999年 | 403篇 |
1998年 | 316篇 |
1997年 | 206篇 |
1996年 | 162篇 |
1995年 | 123篇 |
1994年 | 120篇 |
1993年 | 88篇 |
1992年 | 67篇 |
1991年 | 52篇 |
1990年 | 47篇 |
1989年 | 38篇 |
1988年 | 44篇 |
1987年 | 37篇 |
1986年 | 29篇 |
1985年 | 68篇 |
1984年 | 44篇 |
1983年 | 29篇 |
1982年 | 24篇 |
1981年 | 17篇 |
1980年 | 37篇 |
1979年 | 28篇 |
1978年 | 12篇 |
1977年 | 7篇 |
1974年 | 7篇 |
1972年 | 12篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
31.
32.
《European journal of surgical oncology》2022,48(5):1104-1109
BackgroundThis study aimed to describe the treatment of metachronous colorectal cancer metastases in a recent population-based cohort.MethodPatients with stage I-III colorectal cancer (CRC), diagnosed between January 1st and June 30th, 2015 who were surgically treated with curative intent were selected from the Netherlands Cancer Registry. Follow-up was at least 3 years after diagnosis of the primary tumour. Treatment of metachronous metastases was categorized into local treatment, systemic treatment, and best supportive care. Overall survival was estimated using Kaplan-Meier method.ResultsOut of 5412 patients, 782 (14%) developed metachronous metastases, of whom 393 (50%) underwent local treatment (LT) with or without systemic therapy, 30% of patients underwent only systemic therapy (ST) and 19% only best supportive care (BSC). The most common metastatic site was the liver (51%) followed by lungs (33%) and peritoneum (22%). LT rates were 69%, 66%, and 44% for liver-only, lung-only and, peritoneal-only metastases respectively. Patients receiving LT and ST were significantly younger than patients receiving LT alone, while patients receiving BSC were significantly older than the other groups (p < 0.001). Patients with liver-only or lung-only metastases had a 3-year OS of 50.2% (43.3–56.7 95% CI) and 61.5% (50.7–70.6 95% CI) respectively. Patients with peritoneal-only disease had a lower 3-year OS, 18.1% (10.1–28.0 95% CI).ConclusionPatients with metastases confined to the liver and lung have the highest rates of local treatment for metachronous metastatic colorectal cancer. The number of patients who underwent local treatment is higher than reported in previous Dutch and international studies. 相似文献
33.
34.
35.
Marc Evans MD Susanne Engberg MD Mads Faurby MSc João Diogo Da Rocha Fernandes MSc Pollyanna Hudson MSc William Polonsky PhD 《Diabetes, obesity & metabolism》2022,24(3):377-390
We designed a systematic literature review to identify available evidence on adherence to and persistence with antidiabetic medication in people with type 2 diabetes (T2D). Electronic screening and congress searches identified real-world noninterventional studies (published between 2010 and October 2020) reporting estimates of adherence to and persistence with antidiabetic medication in adults with T2D, and associations with glycaemic control, microvascular and/or macrovascular complications, hospitalizations and healthcare costs. Ninety-two relevant studies were identified, the majority of which were retrospective and reported US data. The proportions of patients considered adherent (median [range] 51.2% [9.4%-84.3%]) or persistent (median [range] 47.7% [16.9%-94.0%]) varied widely across studies. Multiple studies reported an association between greater adherence/persistence and greater reductions in glycated haemoglobin levels. Better adherence/persistence was associated with fewer microvascular and/or macrovascular outcomes, although there was little consistency across studies in terms of which outcomes were improved. More adherent and more persistent patients were typically less likely to be hospitalized or to have emergency department visits/admissions and spent fewer days in hospital annually than less adherent/persistent patients. Greater adherence and persistence were generally associated with lower hospitalization costs, higher pharmacy costs and lower or budget-neutral total healthcare costs compared with lower adherence/persistence. In conclusion, better adherence and persistence in people with T2D is associated with lower rates of microvascular and/or macrovascular outcomes and inpatient hospitalization, and lower or budget-neutral total healthcare expenditure. Education and treatment strategies to address suboptimal adherence and persistence are needed to improve clinical and economic outcomes. 相似文献
36.
Salvatore Greco Beatrice Bonsi Nicol Fabbri 《World Journal of Experimental Medicine》2022,12(5):104-107
Even if the relationships between nutrition and inflammatory bowel disease (IBD) remain underexplored, the current literature is providing, day by day, much more evidence on the effects of various diets in both prevention and treatment of such illnesses. Wrong dietary habits, together with other environmental factors such as pollution, breastfeeding, smoke, and/or antibiotics, are among the theoretical pathogenetic causes of IBD, whose multifactorial aetiology has been already confirmed. While some of these risk factors are potentially reversible, some others cannot be avoided, and efficient treatments become necessary to prevent IBD spread or recurrence. Furthermore, the drugs currently available for treatment of such disease provide low-to-no effect against the symptoms, making the illnesses still strongly disabling. Whether nutrition and specific diets will prove to effectively interrupt the course of IBD has still to be clarified and, in this sense, further research concerning the applications of such dietary interventions is still needed. 相似文献
37.
38.
ObjectiveTo investigate the feasibility of transnasal heated humidified high flow nasal cannula oxygen therapy (HFNC) in the treatment of acute exacerbation of chronic obstructive pulmonary disease (AECOPD) with respiratory failure in elderly patients. MethodsA total of 176 elderly patients with AECOPD complicated with respiratory failure who were hospitalized at Peking University Shougang Hospital from December 2016 to January 2022 were enrolled, including 82 patients in an HFNC group and 94 patients in an NPPV group. After treatment, pulse oxygen saturation (SPO2), arterial partial pressure of carbon dioxide (PaCO2), oxygenation index (OI), respiratory rate (RR), heart rate (HR), mean arterial pressure (MAP), comfort score, discharge rate, rate of endotracheal intubation, rate of transfer to intensive care unit (ICU), and mortality were compared between the two groups. The independent sample t-test was used for comparison between the two groups. Statistical data are expressed in percentage or number of cases and the χ2 test was used for their comparisons. ResultsThe SPO2 values at 30 min, 1 h, and 6 h were significantly higher in the HFNC group than in the NPPV group (t=-2.049,-2.618, and -3.314, P=0.043, 0.010, and 0.001, respectively). SPO2 before discharge was significantly lower than that of the NPPV group (t=2.162, P=0.033), but OI at each time point and before discharge had no statistical significance (P>0.05). MAP at 6 h was significantly higher in the HFNC group than in the NPPV group (t=-2.209, P=0.029), but within the normal range. HRs at 2 h and 3 h in the HFNC group were significantly higher than those of the NPPV group (t=-2.199 and -2.336, P=0.030 and 0.021, respectively). There were no significant differences in RR, HR, or MAP between the two groups at other time points and before discharge (P>0.05). There was no significant difference in PaCO2 between the two groups (P>0.05). Comfort score in the HFNC group was significantly higher than that of the NPPV group (t=-46.807, P<0.001). There were no significant differences in discharge rate, ICU transfer rate, endotracheal intubation rate, and mortality between the two groups (P>0.05). ConclusionHFNC is as effective as NPPV in treating elderly patients with AECOPD complicated with type Ⅰ or mild type Ⅱ respiratory failure, and HFNC is more comfortable than NPPV. 相似文献
39.
目的评价不同手术方式治疗慢性肛裂的效果。
方法通过计算机检索传统肛裂切除术、纵切横缝法、改良纵切横缝术、肛裂切除术+外括约肌切开术、肛裂切除术+内括约肌切开术5种手术治疗慢性肛裂的国内外临床研究,采用Stata13及GeMTC软件对其治愈率和并发症发生率进行传统Meta分析和网状Meta分析。
结果共纳入21项临床研究2 430例患者。网状Meta分析显示肛裂切除术+内括约肌切开术和肛裂切除术+外括约肌切开术的治愈率均高于传统肛裂切除术,OR值分别为2.27(95%CI=1.14~4.36)、3.26(95%CI=1.67~6.75)。在并发症的发生率方面,纵切横缝术、传统肛裂切除术排前两位,肛裂切除术+内括约肌切开术最低。
结论在5种常见的慢性肛裂手术方式中,肛裂切除术+内括约肌切开术的疗效和并发症发生均优于传统肛裂切除术、纵切横缝法、改良纵切横缝术、肛裂切除术+外括约肌切开术。 相似文献
40.
结肠癌患者预后较差,全身系统治疗为目前常用基本策略。近年来的相关研究证据表明,发生在左半结肠和右半结肠的肿瘤病理学特征、分子发病机制及预后存在差异。目前对左、右半结肠癌之间存在的这种异质性差异尚无明确的区分对待策略,国内外指南也尚无定论,因而研究其临床病理特征及相关预后差异具有重要临床意义。笔者在复习相关文献的基础上,就此作一综述。 相似文献